Published in Pharma Law Weekly, December 8th, 2009
"As she was making these medication changes, the patient discovered that she was pregnant. The methotrexate was soon discontinued, but she was still taking it for at least the first 3 weeks of her pregnancy. The patient delivered a full-term female infant who did not appear to have any methotrexate-related birth defects,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly